These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16242075)

  • 21. Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells.
    Herberger B; Berger W; Puhalla H; Schmid K; Novak S; Brandstetter A; Pirker C; Gruenberger T; Filipits M
    Mol Cancer Ther; 2009 Jun; 8(6):1547-56. PubMed ID: 19509244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetaminophen improves protein translational signaling in aged skeletal muscle.
    Wu M; Liu H; Fannin J; Katta A; Wang Y; Arvapalli RK; Paturi S; Karkala SK; Rice KM; Blough ER
    Rejuvenation Res; 2010 Oct; 13(5):571-9. PubMed ID: 20818934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
    Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
    Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.
    Mita MM; Mita A; Rowinsky EK
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S169-77. PubMed ID: 14508096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin.
    Shu L; Zhang X; Houghton PJ
    J Biol Chem; 2002 May; 277(19):16726-32. PubMed ID: 11875068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute alcohol intoxication enhances myocardial eIF4G phosphorylation despite reducing mTOR signaling.
    Vary TC; Deiter G; Goodman SA
    Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H121-8. PubMed ID: 15388509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity.
    Huang S; Shu L; Easton J; Harwood FC; Germain GS; Ichijo H; Houghton PJ
    J Biol Chem; 2004 Aug; 279(35):36490-6. PubMed ID: 15218033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin.
    Dilling MB; Germain GS; Dudkin L; Jayaraman AL; Zhang X; Harwood FC; Houghton PJ
    J Biol Chem; 2002 Apr; 277(16):13907-17. PubMed ID: 11847216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells.
    Bianchini A; Loiarro M; Bielli P; Busà R; Paronetto MP; Loreni F; Geremia R; Sette C
    Carcinogenesis; 2008 Dec; 29(12):2279-88. PubMed ID: 18809972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
    Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
    J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. eIF4E-Overexpression imparts perillyl alcohol and rapamycin-mediated regulation of telomerase reverse transcriptase.
    Sundin T; Peffley D; Hentosh P
    Exp Cell Res; 2013 Aug; 319(13):2103-2112. PubMed ID: 23747720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation.
    Cope CL; Gilley R; Balmanno K; Sale MJ; Howarth KD; Hampson M; Smith PD; Guichard SM; Cook SJ
    J Cell Sci; 2014 Feb; 127(Pt 4):788-800. PubMed ID: 24363449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.
    Hara K; Maruki Y; Long X; Yoshino K; Oshiro N; Hidayat S; Tokunaga C; Avruch J; Yonezawa K
    Cell; 2002 Jul; 110(2):177-89. PubMed ID: 12150926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
    Martin D; Nguyen Q; Molinolo A; Gutkind JS
    Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shiga toxins activate translational regulation pathways in intestinal epithelial cells.
    Colpoys WE; Cochran BH; Carducci TM; Thorpe CM
    Cell Signal; 2005 Jul; 17(7):891-9. PubMed ID: 15763431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
    Beugnet A; Tee AR; Taylor PM; Proud CG
    Biochem J; 2003 Jun; 372(Pt 2):555-66. PubMed ID: 12611592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.